Skip to main content

Table 1 Demographic and clinical characteristics of 185 patients according to COPD phenotypes

From: Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia – a cross-sectional study

Characteristic

No. of patients, n

185

COPD phenotype, n (%)

NON-AE

108 (58.4)

ACO

26 (14.1)

AE

51 (27.6)

p-value

Age, years (mean ± SD, 95% CI)

62.5 ±11.9;

60.5 ± 11.6;

60.5 ± 14.0;

67.9 ± 10.0;

0.001

60.8 − 64.3

58.3–62.7

54.9–66.2

65.1–70.7

Gender, n (%)

 Male

142 (76.8)

83 (76.9)

15 (57.7)

44 (86.3)

0.019

 Female

43 (23.2)

25 (23.1)

11 (42.3)

7 (13.7)

Ethnicity, n (%)

 Malay

31 (16.8)

12 (11.1)

6 (23.1)

13 (25.5)

0.161

 Chinese

20 (10.8)

14 (13.0)

2 (7.7)

4 (7.8)

 

 Native of the state of Sarawak

134 (72.4)

82 (75.9)

18 (69.2)

34 (66.7)

 

Smoking status, n (%)

 Never smoker

57 (30.9)

35 (32.4)

11 (42.3)

11 (21.6)

0.151

 Ex- or current smoker

128 (69.1)

73 (67.6)

15 (57.7)

40 (78.4)

 

Biomass fuel exposure, n (%)

0.249

 No

63 (34.1)

34 (31.5)

7 (26.9)

22 (43.1)

 Yes

122 (65.9)

74 (68.5)

19 (73.1)

29 (56.9)

Risk for COPD, n (%)

0.430

 Cigarette smoking

63 (34.1)

34 (31.5)

7 (26.9)

22 (43.1)

 Biomass fuel exposure

49 (26.5)

31 (28.7)

10 (38.5)

8 (15.7)

 Both

73 (39.4)

43 (39.8)

9 (34.6)

21 (41.2)

Smoking intensity, pack-years (mean ± SD, 95% CI)

17.1 ±16.9;

14.3 ± 14.2;

18.1 ± 19.6;

22.5 ± 19.5;

0.016

14.7 − 19.6

11.6–17.0

10.2–26.0

17.0–28.0

PB- FEV1, % (mean ± SD, 95% CI)

42.8 ±19.5;

43.6 ± 20.1;

44.4 ± 17.9;

40.4 ± 19.3.

0.566

40.0–45.7

39.8–47.4

37.2–51.7

34.9–45.8

Exacerbations, episode (mean ± SD, 95% CI)

 Total

1.4 ±2.7;

0.2 ± 0.4;

0.2 ± 0.4;

4.7 ± 3.4;

<  0.001

1.0–1.8

0.1–0.3

0.1–0.4

3.8–5.7

 Moderate

1.1 ±2.2;

0.2 ± 0.4;

0.2 ± 0.4;

3.6 ± 2.9;

<  0.001

0.8 − 1.4

0.1–0.3

0.1–0.4

2.8–4.4

 Severe

0.3 ±0.8;

0

0

1.1 ± 1.2;

<  0.001

0.2 − 0.4

0.8–1.5

  1. Abbreviation: COPD chronic obstructive pulmonary disease, NON-AE non-exacerbators, ACO asthma-COPD overlap, AE frequent exacerbators, PB-FEV1 post bronchodilator forced expiratory volume in 1 s, SD standard deviation; 95% CI, 95% confidence interval
  2. p-values with bold are significant